19-11212067-G-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_020812.4(DOCK6):c.4576C>T(p.Arg1526Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,611,358 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_020812.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DOCK6 | NM_020812.4 | c.4576C>T | p.Arg1526Ter | stop_gained | 36/48 | ENST00000294618.12 | NP_065863.2 | |
LOC105372273 | NR_134909.1 | n.538-4070G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DOCK6 | ENST00000294618.12 | c.4576C>T | p.Arg1526Ter | stop_gained | 36/48 | 1 | NM_020812.4 | ENSP00000294618 | A2 | |
ENST00000588634.1 | n.538-4070G>A | intron_variant, non_coding_transcript_variant | 4 | |||||||
DOCK6 | ENST00000587656.6 | c.4681C>T | p.Arg1561Ter | stop_gained | 37/49 | 5 | ENSP00000468638 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152042Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000205 AC: 5AN: 244258Hom.: 0 AF XY: 0.0000150 AC XY: 2AN XY: 133018
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1459316Hom.: 0 Cov.: 38 AF XY: 0.0000179 AC XY: 13AN XY: 725660
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152042Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74262
ClinVar
Submissions by phenotype
Adams-Oliver syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 08, 2016 | The p.Arg1526X variant in DOCK6 has not been reported in individuals with Adams- Oliver syndrome. It is a nonsense variant that leads to a premature termination codon at position 1526, which is predicted to lead to a truncated or absent prot ein. This variant has been identified in 3/98220 of chromosomes by the Exome Agg regation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs374530179) th ough its frequency is low enough to be consistent with a recessive carrier frequ ency. In summary, although additional studies are required to fully establish it s clinical significance, the p.Arg1526X variant is likely pathogenic for Adams-O liver syndrome in a recessive manner based upon predicted loss of function of th e protein. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 07, 2023 | This sequence change creates a premature translational stop signal (p.Arg1526*) in the DOCK6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DOCK6 are known to be pathogenic (PMID: 21820096, 25824905). This variant is present in population databases (rs374530179, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with DOCK6-related conditions. ClinVar contains an entry for this variant (Variation ID: 504926). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at